Retraction
Targeted non AR mediated smart delivery of abiraterone to the prostate cancer
Paper Information
Record ID:
64886
Author(s):
Publication Date:
August 26, 2022
Retraction Date:
April 02, 2025
(<1 year years ago)
Subjects:
Institutions:
- Nanomedicine & Nanobiotechnology Lab, Department of Biosciences, Integral University, Lucknow, India
- Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abduaziz University, Al-kharj, Saudi Arabia
- Department of Physics, SRM University-AP, Amaravati, India
- Department of Biochemistry, Aligarh Muslim University, Aligarh, India
Countries:
Article Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0321800Citations (7)
7
Total Citations0
Post-Retraction5
Pre-Retraction1
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Retraction: Targeted non AR mediated smart delivery of abiraterone to the prostate cancer
Unknown Authors
PLoS ONE
Open Access
Published: Apr 2025
Same day as retraction
Preparation, characterization and antioxidant and anticancerous potential of Quercetin loaded β-glucan particles derived from mushroom and yeast
Rashmi Trivedi, Tarun Kumar Upadhyay
Scientific Reports
Open Access
Published: Jul 2024
3 citations
3 citations
265 days before retraction
Survivin-targeted nanomedicine for increased potency of abiraterone and enzalutamide against prostate cancer
Abu Baker, Asad Syed, Mohamed Mohany et al. (6 authors)
European Journal of Pharmaceutics and Biopharmaceutics
Published: Oct 2023
3 citations
3 citations
546 days before retraction
IgG antibodies mediated gold nanoparticles conjugated to methotrexate as targeted chemotherapy for lung cancer
Asad Syed, Abu Baker, Mohamed Mohany et al. (6 authors)
Artificial Cells Nanomedicine and Biotechnology
Open Access
Published: Aug 2023
4 citations
4 citations
604 days before retraction
Optimizing Abiraterone Delivery through Intratumoral In Situ Implant: A Prospective Pharmaceutical Development Approach
Е. О. Бахрушина, Liliya M. Buraya, Egor D. Moiseev et al. (6 authors)
Sciences of Pharmacy
Open Access
Published: May 2023
695 days before retraction
Synthesis and Preclinical Evaluation of Small-Molecule Prostate-Specific Membrane Antigen-Targeted Abiraterone Conjugate
Aleksei E. Machulkin, Ekaterina A. Nimenko, Nikolay U. Zyk et al. (17 authors)
Molecules
Open Access
Published: Dec 2022
9 citations
9 citations
842 days before retraction
Quick Stats
Total Citations:
10
Years Since Retraction:
<1 year
Open Access:
Yes
Last Checked:
Jul 23, 2025